Illinois Gov. Rod Blagojevich is asking for a state investigation into whether drug manufacturers are illegally blocking access to cheaper prescription drugs from Canada.
In a Thursday announcement, Blagojevich's office said the governor is calling on Illinois Attorney General Lisa Madigan to investigate "possible antitrust violations" by at least four drugmakers "who are fighting to keep U.S. consumers from obtaining prescription medications on the lower priced Canadian market."
The four drugmakers named in the announcement are London-based GlaxoSmithKline, London-based AstraZeneca PLC, Madison, N.J.-based Wyeth and New York City-based Pfizer.
"If drug-makers are acting in a manner that hurts seniors and other consumers in Illinois, then we're going to do something about it," Blagojevich says.
The Illinois news follows an announcement on Tuesday by Minnesota Attorney General Mike Hatch that he will investigate GlaxoSmithKline for an alleged boycott of Canadian pharmacies that import drugs to the United States.
According to Hatch, GlaxoSmithKline has notified Canadian wholesalers and pharmacies that it will stop supplying them with its pharmaceuticals if they sell drugs to United States citizens.